Katie Korgaokar.

GAO list of FDA management of medical equipment with a ‘high risk ‘designation in 2009The hearing raised which story of Mrs. Katie Korgaokar, a Denver-based, the one DePuy ASR hip implant, a congenital condition called Perthes disease receive treatment in 2010, the DePuy hip recall and Korgaokar suffered a second hip replacement surgery in the spring of 2011 Korgaokar was one of 96,000 patients from the DePuy affected hip recall.

.. Synexus recruits 20 percent of patients in Crestor Jupiter Study, UKrecruits With only eight of its 14 hub sites Synexus and randomized more than 2,740 of the 15,000 patients in AstraZeneca’s Crestor Jupiter study are involved in cardiovascular disease.The study was stopped early, there is clear evidence of a reduction in cardiovascular morbidity and mortality was carried out in 1,200 locations in 26 countries.The Synexus model with full-time investigators at its hub sites by reducing the cost of running clinical trials that monitor a negotiation and contract instead of hundreds and a handful of websites.Synexus is planning to expand in the U.S.The scientists well as found, continuum of The primary endpoints to the SSEDs reports the findings of 15 per cent were noninterpretable. The most common cause was that no goal gate for the unit performance a 25 end points has noted, and in one case results were not reported. Which authors say: ‘In some cases, end points of designed order to achieve their did ‘ve merely met a of them. ‘.